Globalstar, Inc. (OTCBB: GSAT) recently announced that it received a delisting notice from NASDAQ do to the fact that it's share price has fallen below $1.00 per share in excess of the time period permitted by NASDAQ rules. The company after a recent appeal to NASDAQ requested a further extension and was denied.
The six time patent infringement in pharmaceuticals case plaintiff Depomed (NASDAQ: DEPO) is making progress in battles. Watson Pharmaceuticals (NYSE: WPI) withdrew its application for the competing drug generic Gralise, and the suit against Impax Laboratories (NASDAQ: IPXL) was dismissed after the withdrawal of their application. The road is getting clearer as the competition is fading. Look for Depomed to react.